Abstract: Provided is crystal form A of N, N?-(10, 17-dioxo-3, 6, 21, 24-tetraoxa-9, 11, 16, 18-tetrazohexahexane-1, 26-di-yl)bis(4-(6, 8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline-4-yl) benzene sulfonamide. The crystal form has good light stability, high-temperature stability, and high-humidity stability.

Abstract: Forms B and C of (R)—N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide are stable under the conditions of light, high temperature and high humidity.

Abstract: Forms B and C of (R)—N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide are stable under the conditions of light, high temperature and high humidity.

Abstract: A vehicle braking energy recovering method includes obtaining current location information of a vehicle, determining a current road scenario based on the current location information of the vehicle, determining the current road scenario based on a mapping relationship between a road scenario and a weight, determining a safe distance and a safe speed of the vehicle based on the weight, determining a target torque based on the safe distance and the safe speed of the vehicle, and controlling, based on the target torque, a motor of the vehicle to recover braking energy.

Abstract: One embodiment relates to a method of treating cancer by administering a compound of Formula I to a patient.

Abstract: Protein kinase C plays important roles in TNBC development and could be a specific target. The in vitro anti-proliferative activity of PKC inhibitor chelerythrine on a panel of breast cancer cell lines was evaluated. Chelerythrine selectively inhibited the growth of TNBC cell lines over non-TNBC cell lines as demonstrated by cell proliferation assay and colony formation assay. The selective anti-proliferative effect of chelerythrine was associated with the differential apoptosis induction ability on breast cancer cell lines and induction of cell cycle arrest in some TNBC cell lines. By analysis of the expression levels of different PKC subtypes, the inventors found multiple PKC isozymes may mediate the selective activity of chelerythrine on TNBC cells. Finally, combination of chelerythrine and chemotherapy reagent taxol showed synergistic/additive effect on TNBC cell lines.

Abstract: A battery case is provided, comprising a cylindrical body (1), a top cover plate (3) and a bottom cover plate (4). The cylindrical body (1) comprises a top which is open and covered with the top cover plate (3) fixed thereto, and the cylindrical body (1) further comprises a bottom configured to be a supporting surface (8) having an opening (2). The opening (2) of the supporting surface (8) is configured to be covered with the bottom cover plate (4). Further, the opening (2) is configured to be a stepped opening or a conical opening. Still further, a first groove (12) is arranged on an exterior surface of the bottom surrounding the opening (2), and a second groove (13) is arranged on an exterior surface of the bottom cover plate next to the opening (2) of the bottom. A battery made of the battery case is also provided.